MVP medical developments international limited
Add to My Watchlist 0.00% ! 67.5¢

News: MVP Medical Developments International Ltd Sees FY Underlying Profit $0.3 Mln

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    14/05/18
    16:20
    Post #: 33082906

    May 14 (Reuters) - Medical Developments International Ltd (MVP) :

    • GROSS REVENUE FOR FY18 WILL LIKELY BE FLAT OR SLIGHTLY DOWN ON FY17
    • UNDERLYING PROFIT FOR FY18 IS EXPECTED TO BE $0.3 MILLION
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 025 – Locksley rap video gives Hilltop Hoods run for money
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
67.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $76.04M
Open High Low Value Volume
68.0¢ 69.0¢ 66.5¢ $138.8K 203.7K

Buyers (Bids)

No. Vol. Price($)
2 14989 67.5¢
 

Sellers (Offers)

Price($) Vol. No.
69.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 18/09/2025 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.